Shopping Cart 0
Cart Subtotal
AED 0

Global Mesalamine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 35819

Details

Scope of the Report:

The worldwide market for Mesalamine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2024, from xx million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Mesalamine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Allergan

Pfizer

AstraZeneca

Salix Pharmaceuticals

Janssen (Johnson & Johnson)

Nogra Pharma

Boehringer Ingelheim

Takeda

Abbvie

Ferring

Tillotts Pharma

Cipla

Cosmo Pharmaceuticals

Lunan Better Pharmaceutical

Chiesi Farmaceutici

Sandoz Mesalamine

Teva

Synmosa Biopharma Corporation

Dr Falk Pharma

Mylan

Shanghai Sine Promod Pharmaceutical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Capsule

Tablets

Market Segment by Applications, can be divided into

Adult

Children

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Mesalamine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Mesalamine, with price, sales, revenue and global market share of Mesalamine in 2017 and 2018.

Chapter 3, the Mesalamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Mesalamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Mesalamine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Mesalamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Mesalamine Introduction

1.2 Market Analysis by Type

1.2.1 Capsule

1.2.2 Tablets

1.3 Market Analysis by Applications

1.3.1 Adult

1.3.2 Children

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Allergan

2.1.1 Business Overview

2.1.2 Mesalamine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Allergan Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Pfizer

2.2.1 Business Overview

2.2.2 Mesalamine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Pfizer Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 AstraZeneca

2.3.1 Business Overview

2.3.2 Mesalamine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AstraZeneca Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Salix Pharmaceuticals

2.4.1 Business Overview

2.4.2 Mesalamine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Salix Pharmaceuticals Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Janssen (Johnson & Johnson)

2.5.1 Business Overview

2.5.2 Mesalamine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Janssen (Johnson & Johnson) Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Nogra Pharma

2.6.1 Business Overview

2.6.2 Mesalamine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Nogra Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Boehringer Ingelheim

2.7.1 Business Overview

2.7.2 Mesalamine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Boehringer Ingelheim Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Takeda

2.8.1 Business Overview

2.8.2 Mesalamine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Takeda Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Abbvie

2.9.1 Business Overview

2.9.2 Mesalamine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Abbvie Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Ferring

2.10.1 Business Overview

2.10.2 Mesalamine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Ferring Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.11 Tillotts Pharma

2.11.1 Business Overview

2.11.2 Mesalamine Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Tillotts Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.12 Cipla

2.12.1 Business Overview

2.12.2 Mesalamine Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Cipla Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.13 Cosmo Pharmaceuticals

2.13.1 Business Overview

2.13.2 Mesalamine Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Cosmo Pharmaceuticals Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.14 Lunan Better Pharmaceutical

2.14.1 Business Overview

2.14.2 Mesalamine Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Lunan Better Pharmaceutical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.15 Chiesi Farmaceutici

2.15.1 Business Overview

2.15.2 Mesalamine Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Chiesi Farmaceutici Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.16 Sandoz Mesalamine

2.16.1 Business Overview

2.16.2 Mesalamine Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Sandoz Mesalamine Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.17 Teva

2.17.1 Business Overview

2.17.2 Mesalamine Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Teva Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.18 Synmosa Biopharma Corporation

2.18.1 Business Overview

2.18.2 Mesalamine Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Synmosa Biopharma Corporation Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.19 Dr Falk Pharma

2.19.1 Business Overview

2.19.2 Mesalamine Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Dr Falk Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.20 Mylan

2.20.1 Business Overview

2.20.2 Mesalamine Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Mylan Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.21 Shanghai Sine Promod Pharmaceutical

2.21.1 Business Overview

2.21.2 Mesalamine Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 Shanghai Sine Promod Pharmaceutical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Mesalamine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Mesalamine Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Mesalamine Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Mesalamine Manufacturer Market Share in 2018

3.3.2 Top 6 Mesalamine Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Mesalamine Market Analysis by Regions

4.1 Global Mesalamine Sales, Revenue and Market Share by Regions

4.1.1 Global Mesalamine Sales and Market Share by Regions (2014-2019)

4.1.2 Global Mesalamine Revenue and Market Share by Regions (2014-2019)

4.2 North America Mesalamine Sales and Growth Rate (2014-2019)

4.3 Europe Mesalamine Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Mesalamine Sales and Growth Rate (2014-2019)

4.5 South America Mesalamine Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Mesalamine Sales and Growth Rate (2014-2019)

5 North America Mesalamine by Country

5.1 North America Mesalamine Sales, Revenue and Market Share by Country

5.1.1 North America Mesalamine Sales and Market Share by Country (2014-2019)

5.1.2 North America Mesalamine Revenue and Market Share by Country (2014-2019)

5.2 United States Mesalamine Sales and Growth Rate (2014-2019)

5.3 Canada Mesalamine Sales and Growth Rate (2014-2019)

5.4 Mexico Mesalamine Sales and Growth Rate (2014-2019)

6 Europe Mesalamine by Country

6.1 Europe Mesalamine Sales, Revenue and Market Share by Country

6.1.1 Europe Mesalamine Sales and Market Share by Country (2014-2019)

6.1.2 Europe Mesalamine Revenue and Market Share by Country (2014-2019)

6.2 Germany Mesalamine Sales and Growth Rate (2014-2019)

6.3 UK Mesalamine Sales and Growth Rate (2014-2019)

6.4 France Mesalamine Sales and Growth Rate (2014-2019)

6.5 Russia Mesalamine Sales and Growth Rate (2014-2019)

6.6 Italy Mesalamine Sales and Growth Rate (2014-2019)

7 Asia-Pacific Mesalamine by Country

7.1 Asia-Pacific Mesalamine Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Mesalamine Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Mesalamine Revenue and Market Share by Country (2014-2019)

7.2 China Mesalamine Sales and Growth Rate (2014-2019)

7.3 Japan Mesalamine Sales and Growth Rate (2014-2019)

7.4 Korea Mesalamine Sales and Growth Rate (2014-2019)

7.5 India Mesalamine Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Mesalamine Sales and Growth Rate (2014-2019)

8 South America Mesalamine by Country

8.1 South America Mesalamine Sales, Revenue and Market Share by Country

8.1.1 South America Mesalamine Sales and Market Share by Country (2014-2019)

8.1.2 South America Mesalamine Revenue and Market Share by Country (2014-2019)

8.2 Brazil Mesalamine Sales and Growth Rate (2014-2019)

8.3 Argentina Mesalamine Sales and Growth Rate (2014-2019)

8.4 Colombia Mesalamine Sales and Growth Rate (2014-2019)

9 Middle East and Africa Mesalamine by Countries

9.1 Middle East and Africa Mesalamine Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Mesalamine Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Mesalamine Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Mesalamine Sales and Growth Rate (2014-2019)

9.3 Turkey Mesalamine Sales and Growth Rate (2014-2019)

9.4 Egypt Mesalamine Sales and Growth Rate (2014-2019)

9.5 Nigeria Mesalamine Sales and Growth Rate (2014-2019)

9.6 South Africa Mesalamine Sales and Growth Rate (2014-2019)

10 Global Mesalamine Market Segment by Type

10.1 Global Mesalamine Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Mesalamine Sales and Market Share by Type (2014-2019)

10.1.2 Global Mesalamine Revenue and Market Share by Type (2014-2019)

10.2 Capsule Sales Growth and Price

10.2.1 Global Capsule Sales Growth (2014-2019)

10.2.2 Global Capsule Price (2014-2019)

10.3 Tablets Sales Growth and Price

10.3.1 Global Tablets Sales Growth (2014-2019)

10.3.2 Global Tablets Price (2014-2019)

11 Global Mesalamine Market Segment by Application

11.1 Global Mesalamine Sales Market Share by Application (2014-2019)

11.2 Adult Sales Growth (2014-2019)

11.3 Children Sales Growth (2014-2019)

12 Mesalamine Market Forecast (2019-2024)

12.1 Global Mesalamine Sales, Revenue and Growth Rate (2019-2024)

12.2 Mesalamine Market Forecast by Regions (2019-2024)

12.2.1 North America Mesalamine Market Forecast (2019-2024)

12.2.2 Europe Mesalamine Market Forecast (2019-2024)

12.2.3 Asia-Pacific Mesalamine Market Forecast (2019-2024)

12.2.4 South America Mesalamine Market Forecast (2019-2024)

12.2.5 Middle East and Africa Mesalamine Market Forecast (2019-2024)

12.3 Mesalamine Market Forecast by Type (2019-2024)

12.3.1 Global Mesalamine Sales Forecast by Type (2019-2024)

12.3.2 Global Mesalamine Market Share Forecast by Type (2019-2024)

12.4 Mesalamine Market Forecast by Application (2019-2024)

12.4.1 Global Mesalamine Sales Forecast by Application (2019-2024)

12.4.2 Global Mesalamine Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Figure

List of Tables and Figures

Figure Mesalamine Picture

Table Product Specifications of Mesalamine

Figure Global Sales Market Share of Mesalamine by Types in 2018

Table Mesalamine Types for Major Manufacturers

Figure Capsule Picture

Figure Tablets Picture

Figure Mesalamine Sales Market Share by Applications in 2018

Figure Adult Picture

Figure Children Picture

Figure United States Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure France Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure UK Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure China Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure India Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Mesalamine Type and Applications

Table Allergan Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Mesalamine Type and Applications

Table Pfizer Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Mesalamine Type and Applications

Table AstraZeneca Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Salix Pharmaceuticals Mesalamine Type and Applications

Table Salix Pharmaceuticals Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Janssen (Johnson & Johnson) Basic Information, Manufacturing Base and Competitors

Table Janssen (Johnson & Johnson) Mesalamine Type and Applications

Table Janssen (Johnson & Johnson) Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Nogra Pharma Basic Information, Manufacturing Base and Competitors

Table Nogra Pharma Mesalamine Type and Applications

Table Nogra Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors

Table Boehringer Ingelheim Mesalamine Type and Applications

Table Boehringer Ingelheim Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Takeda Basic Information, Manufacturing Base and Competitors

Table Takeda Mesalamine Type and Applications

Table Takeda Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Abbvie Basic Information, Manufacturing Base and Competitors

Table Abbvie Mesalamine Type and Applications

Table Abbvie Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Ferring Basic Information, Manufacturing Base and Competitors

Table Ferring Mesalamine Type and Applications

Table Ferring Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Tillotts Pharma Basic Information, Manufacturing Base and Competitors

Table Tillotts Pharma Mesalamine Type and Applications

Table Tillotts Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Mesalamine Type and Applications

Table Cipla Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Cosmo Pharmaceuticals Mesalamine Type and Applications

Table Cosmo Pharmaceuticals Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Lunan Better Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Lunan Better Pharmaceutical Mesalamine Type and Applications

Table Lunan Better Pharmaceutical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors

Table Chiesi Farmaceutici Mesalamine Type and Applications

Table Chiesi Farmaceutici Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Sandoz Mesalamine Basic Information, Manufacturing Base and Competitors

Table Sandoz Mesalamine Mesalamine Type and Applications

Table Sandoz Mesalamine Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Teva Basic Information, Manufacturing Base and Competitors

Table Teva Mesalamine Type and Applications

Table Teva Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Synmosa Biopharma Corporation Basic Information, Manufacturing Base and Competitors

Table Synmosa Biopharma Corporation Mesalamine Type and Applications

Table Synmosa Biopharma Corporation Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Dr Falk Pharma Basic Information, Manufacturing Base and Competitors

Table Dr Falk Pharma Mesalamine Type and Applications

Table Dr Falk Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Mesalamine Type and Applications

Table Mylan Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Shanghai Sine Promod Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Shanghai Sine Promod Pharmaceutical Mesalamine Type and Applications

Table Shanghai Sine Promod Pharmaceutical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Mesalamine Sales by Manufacturer (2017-2018)

Figure Global Mesalamine Sales Market Share by Manufacturer in 2017

Figure Global Mesalamine Sales Market Share by Manufacturer in 2018

Table Global Mesalamine Revenue by Manufacturer (2017-2018)

Figure Global Mesalamine Revenue Market Share by Manufacturer in 2017

Figure Global Mesalamine Revenue Market Share by Manufacturer in 2018

Figure Top 3 Mesalamine Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Mesalamine Manufacturer (Revenue) Market Share in 2018

Figure Global Mesalamine Sales and Growth Rate (2014-2019)

Figure Global Mesalamine Revenue and Growth Rate (2014-2019)

Table Global Mesalamine Sales by Regions (2014-2019)

Table Global Mesalamine Sales Market Share by Regions (2014-2019)

Table Global Mesalamine Revenue by Regions (2014-2019)

Figure Global Mesalamine Revenue Market Share by Regions (2014-2019)

Figure Global Mesalamine Revenue Market Share by Regions in 2018

Figure North America Mesalamine Sales and Growth Rate (2014-2019)

Figure Europe Mesalamine Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Mesalamine Sales and Growth Rate (2014-2019)

Figure South America Mesalamine Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Mesalamine Sales and Growth Rate (2014-2019)

Figure North America Mesalamine Revenue and Growth Rate (2014-2019)

Table North America Mesalamine Sales by Countries (2014-2019)

Table North America Mesalamine Sales Market Share by Countries (2014-2019)

Figure North America Mesalamine Sales Market Share by Countries (2014-2019)

Figure North America Mesalamine Sales Market Share by Countries in 2018

Table North America Mesalamine Revenue by Countries (2014-2019)

Table North America Mesalamine Revenue Market Share by Countries (2014-2019)

Figure North America Mesalamine Revenue Market Share by Countries (2014-2019)

Figure North America Mesalamine Revenue Market Share by Countries in 2018

Figure United States Mesalamine Sales and Growth Rate (2014-2019)

Figure Canada Mesalamine Sales and Growth Rate (2014-2019)

Figure Mexico Mesalamine Sales and Growth Rate (2014-2019)

Figure Europe Mesalamine Revenue and Growth Rate (2014-2019)

Table Europe Mesalamine Sales by Countries (2014-2019)

Table Europe Mesalamine Sales Market Share by Countries (2014-2019)

Table Europe Mesalamine Revenue by Countries (2014-2019)

Figure Europe Mesalamine Revenue Market Share by Countries (2014-2019)

Figure Europe Mesalamine Revenue Market Share by Countries in 2018

Figure Germany Mesalamine Sales and Growth Rate (2014-2019)

Figure UK Mesalamine Sales and Growth Rate (2014-2019)

Figure France Mesalamine Sales and Growth Rate (2014-2019)

Figure Russia Mesalamine Sales and Growth Rate (2014-2019)

Figure Italy Mesalamine Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Mesalamine Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Mesalamine Sales by Countries (2014-2019)

Table Asia-Pacific Mesalamine Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Mesalamine Sales Market Share by Countries 2018

Table Asia-Pacific Mesalamine Revenue by Countries (2014-2019)

Figure Asia-Pacific Mesalamine Revenue Market Share by Countries 2018

Figure China Mesalamine Sales and Growth Rate (2014-2019)

Figure Japan Mesalamine Sales and Growth Rate (2014-2019)

Figure Korea Mesalamine Sales and Growth Rate (2014-2019)

Figure India Mesalamine Sales and Growth Rate (2014-2019)

Figure Southeast Asia Mesalamine Sales and Growth Rate (2014-2019)

Figure South America Mesalamine Revenue and Growth Rate (2014-2019)

Table South America Mesalamine Sales by Countries (2014-2019)

Table South America Mesalamine Sales Market Share by Countries (2014-2019)

Figure South America Mesalamine Sales Market Share by Countries in 2018

Table South America Mesalamine Revenue by Countries (2014-2019)

Table South America Mesalamine Revenue Market Share by Countries (2014-2019)

Figure South America Mesalamine Revenue Market Share by Countries in 2018

Figure Brazil Mesalamine Sales and Growth Rate (2014-2019)

Figure Argentina Mesalamine Sales and Growth Rate (2014-2019)

Figure Colombia Mesalamine Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Mesalamine Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Mesalamine Sales by Countries (2014-2019)

Table Middle East and Africa Mesalamine Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Mesalamine Sales Market Share by Countries in 2018

Table Middle East and Africa Mesalamine Revenue by Countries (2014-2019)

Table Middle East and Africa Mesalamine Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Mesalamine Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Mesalamine Revenue Market Share by Countries in 2018

Figure Saudi Arabia Mesalamine Sales and Growth Rate (2014-2019)

Figure UAE Mesalamine Sales and Growth Rate (2014-2019)

Figure Egypt Mesalamine Sales and Growth Rate (2014-2019)

Figure Nigeria Mesalamine Sales and Growth Rate (2014-2019)

Figure South Africa Mesalamine Sales and Growth Rate (2014-2019)

Table Global Mesalamine Sales by Type (2014-2019)

Table Global Mesalamine Sales Share by Type (2014-2019)

Table Global Mesalamine Revenue by Type (2014-2019)

Table Global Mesalamine Revenue Share by Type (2014-2019)

Figure Global Capsule Sales Growth (2014-2019)

Figure Global Capsule Price (2014-2019)

Figure Global Tablets Sales Growth (2014-2019)

Figure Global Tablets Price (2014-2019)

Table Global Mesalamine Sales by Application (2014-2019)

Table Global Mesalamine Sales Share by Application (2014-2019)

Figure Global Adult Sales Growth (2014-2019)

Figure Global Children Sales Growth (2014-2019)

Figure Global Mesalamine Sales, Revenue and Growth Rate (2019-2024)

Table Global Mesalamine Sales Forecast by Regions (2019-2024)

Table Global Mesalamine Market Share Forecast by Regions (2019-2024)

Figure North America Sales Mesalamine Market Forecast (2019-2024)

Figure Europe Sales Mesalamine Market Forecast (2019-2024)

Figure Asia-Pacific Sales Mesalamine Market Forecast (2019-2024)

Figure South America Sales Mesalamine Market Forecast (2019-2024)

Figure Middle East and Africa Sales Mesalamine Market Forecast (2019-2024)

Table Global Mesalamine Sales Forecast by Type (2019-2024)

Table Global Mesalamine Market Share Forecast by Type (2019-2024)

Table Global Mesalamine Sales Forecast by Application (2019-2024)

Table Global Mesalamine Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Allergan

Pfizer

AstraZeneca

Salix Pharmaceuticals

Janssen (Johnson & Johnson)

Nogra Pharma

Boehringer Ingelheim

Takeda

Abbvie

Ferring

Tillotts Pharma

Cipla

Cosmo Pharmaceuticals

Lunan Better Pharmaceutical

Chiesi Farmaceutici

Sandoz Mesalamine

Teva

Synmosa Biopharma Corporation

Dr Falk Pharma

Mylan

Shanghai Sine Promod Pharmaceutical

Company Profile

Company Profile Title

Scope of the Report:

The worldwide market for Mesalamine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2024, from xx million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Mesalamine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Allergan

Pfizer

AstraZeneca

Salix Pharmaceuticals

Janssen (Johnson & Johnson)

Nogra Pharma

Boehringer Ingelheim

Takeda

Abbvie

Ferring

Tillotts Pharma

Cipla

Cosmo Pharmaceuticals

Lunan Better Pharmaceutical

Chiesi Farmaceutici

Sandoz Mesalamine

Teva

Synmosa Biopharma Corporation

Dr Falk Pharma

Mylan

Shanghai Sine Promod Pharmaceutical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Capsule

Tablets

Market Segment by Applications, can be divided into

Adult

Children

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Mesalamine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Mesalamine, with price, sales, revenue and global market share of Mesalamine in 2017 and 2018.

Chapter 3, the Mesalamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Mesalamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Mesalamine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Mesalamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Mesalamine Introduction

1.2 Market Analysis by Type

1.2.1 Capsule

1.2.2 Tablets

1.3 Market Analysis by Applications

1.3.1 Adult

1.3.2 Children

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Allergan

2.1.1 Business Overview

2.1.2 Mesalamine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Allergan Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Pfizer

2.2.1 Business Overview

2.2.2 Mesalamine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Pfizer Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 AstraZeneca

2.3.1 Business Overview

2.3.2 Mesalamine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AstraZeneca Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Salix Pharmaceuticals

2.4.1 Business Overview

2.4.2 Mesalamine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Salix Pharmaceuticals Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Janssen (Johnson & Johnson)

2.5.1 Business Overview

2.5.2 Mesalamine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Janssen (Johnson & Johnson) Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Nogra Pharma

2.6.1 Business Overview

2.6.2 Mesalamine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Nogra Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Boehringer Ingelheim

2.7.1 Business Overview

2.7.2 Mesalamine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Boehringer Ingelheim Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Takeda

2.8.1 Business Overview

2.8.2 Mesalamine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Takeda Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Abbvie

2.9.1 Business Overview

2.9.2 Mesalamine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Abbvie Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Ferring

2.10.1 Business Overview

2.10.2 Mesalamine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Ferring Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.11 Tillotts Pharma

2.11.1 Business Overview

2.11.2 Mesalamine Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Tillotts Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.12 Cipla

2.12.1 Business Overview

2.12.2 Mesalamine Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Cipla Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.13 Cosmo Pharmaceuticals

2.13.1 Business Overview

2.13.2 Mesalamine Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Cosmo Pharmaceuticals Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.14 Lunan Better Pharmaceutical

2.14.1 Business Overview

2.14.2 Mesalamine Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Lunan Better Pharmaceutical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.15 Chiesi Farmaceutici

2.15.1 Business Overview

2.15.2 Mesalamine Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Chiesi Farmaceutici Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.16 Sandoz Mesalamine

2.16.1 Business Overview

2.16.2 Mesalamine Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Sandoz Mesalamine Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.17 Teva

2.17.1 Business Overview

2.17.2 Mesalamine Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Teva Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.18 Synmosa Biopharma Corporation

2.18.1 Business Overview

2.18.2 Mesalamine Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Synmosa Biopharma Corporation Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.19 Dr Falk Pharma

2.19.1 Business Overview

2.19.2 Mesalamine Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Dr Falk Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.20 Mylan

2.20.1 Business Overview

2.20.2 Mesalamine Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Mylan Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.21 Shanghai Sine Promod Pharmaceutical

2.21.1 Business Overview

2.21.2 Mesalamine Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 Shanghai Sine Promod Pharmaceutical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Mesalamine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Mesalamine Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Mesalamine Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Mesalamine Manufacturer Market Share in 2018

3.3.2 Top 6 Mesalamine Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Mesalamine Market Analysis by Regions

4.1 Global Mesalamine Sales, Revenue and Market Share by Regions

4.1.1 Global Mesalamine Sales and Market Share by Regions (2014-2019)

4.1.2 Global Mesalamine Revenue and Market Share by Regions (2014-2019)

4.2 North America Mesalamine Sales and Growth Rate (2014-2019)

4.3 Europe Mesalamine Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Mesalamine Sales and Growth Rate (2014-2019)

4.5 South America Mesalamine Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Mesalamine Sales and Growth Rate (2014-2019)

5 North America Mesalamine by Country

5.1 North America Mesalamine Sales, Revenue and Market Share by Country

5.1.1 North America Mesalamine Sales and Market Share by Country (2014-2019)

5.1.2 North America Mesalamine Revenue and Market Share by Country (2014-2019)

5.2 United States Mesalamine Sales and Growth Rate (2014-2019)

5.3 Canada Mesalamine Sales and Growth Rate (2014-2019)

5.4 Mexico Mesalamine Sales and Growth Rate (2014-2019)

6 Europe Mesalamine by Country

6.1 Europe Mesalamine Sales, Revenue and Market Share by Country

6.1.1 Europe Mesalamine Sales and Market Share by Country (2014-2019)

6.1.2 Europe Mesalamine Revenue and Market Share by Country (2014-2019)

6.2 Germany Mesalamine Sales and Growth Rate (2014-2019)

6.3 UK Mesalamine Sales and Growth Rate (2014-2019)

6.4 France Mesalamine Sales and Growth Rate (2014-2019)

6.5 Russia Mesalamine Sales and Growth Rate (2014-2019)

6.6 Italy Mesalamine Sales and Growth Rate (2014-2019)

7 Asia-Pacific Mesalamine by Country

7.1 Asia-Pacific Mesalamine Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Mesalamine Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Mesalamine Revenue and Market Share by Country (2014-2019)

7.2 China Mesalamine Sales and Growth Rate (2014-2019)

7.3 Japan Mesalamine Sales and Growth Rate (2014-2019)

7.4 Korea Mesalamine Sales and Growth Rate (2014-2019)

7.5 India Mesalamine Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Mesalamine Sales and Growth Rate (2014-2019)

8 South America Mesalamine by Country

8.1 South America Mesalamine Sales, Revenue and Market Share by Country

8.1.1 South America Mesalamine Sales and Market Share by Country (2014-2019)

8.1.2 South America Mesalamine Revenue and Market Share by Country (2014-2019)

8.2 Brazil Mesalamine Sales and Growth Rate (2014-2019)

8.3 Argentina Mesalamine Sales and Growth Rate (2014-2019)

8.4 Colombia Mesalamine Sales and Growth Rate (2014-2019)

9 Middle East and Africa Mesalamine by Countries

9.1 Middle East and Africa Mesalamine Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Mesalamine Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Mesalamine Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Mesalamine Sales and Growth Rate (2014-2019)

9.3 Turkey Mesalamine Sales and Growth Rate (2014-2019)

9.4 Egypt Mesalamine Sales and Growth Rate (2014-2019)

9.5 Nigeria Mesalamine Sales and Growth Rate (2014-2019)

9.6 South Africa Mesalamine Sales and Growth Rate (2014-2019)

10 Global Mesalamine Market Segment by Type

10.1 Global Mesalamine Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Mesalamine Sales and Market Share by Type (2014-2019)

10.1.2 Global Mesalamine Revenue and Market Share by Type (2014-2019)

10.2 Capsule Sales Growth and Price

10.2.1 Global Capsule Sales Growth (2014-2019)

10.2.2 Global Capsule Price (2014-2019)

10.3 Tablets Sales Growth and Price

10.3.1 Global Tablets Sales Growth (2014-2019)

10.3.2 Global Tablets Price (2014-2019)

11 Global Mesalamine Market Segment by Application

11.1 Global Mesalamine Sales Market Share by Application (2014-2019)

11.2 Adult Sales Growth (2014-2019)

11.3 Children Sales Growth (2014-2019)

12 Mesalamine Market Forecast (2019-2024)

12.1 Global Mesalamine Sales, Revenue and Growth Rate (2019-2024)

12.2 Mesalamine Market Forecast by Regions (2019-2024)

12.2.1 North America Mesalamine Market Forecast (2019-2024)

12.2.2 Europe Mesalamine Market Forecast (2019-2024)

12.2.3 Asia-Pacific Mesalamine Market Forecast (2019-2024)

12.2.4 South America Mesalamine Market Forecast (2019-2024)

12.2.5 Middle East and Africa Mesalamine Market Forecast (2019-2024)

12.3 Mesalamine Market Forecast by Type (2019-2024)

12.3.1 Global Mesalamine Sales Forecast by Type (2019-2024)

12.3.2 Global Mesalamine Market Share Forecast by Type (2019-2024)

12.4 Mesalamine Market Forecast by Application (2019-2024)

12.4.1 Global Mesalamine Sales Forecast by Application (2019-2024)

12.4.2 Global Mesalamine Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Figure

List of Tables and Figures

Figure Mesalamine Picture

Table Product Specifications of Mesalamine

Figure Global Sales Market Share of Mesalamine by Types in 2018

Table Mesalamine Types for Major Manufacturers

Figure Capsule Picture

Figure Tablets Picture

Figure Mesalamine Sales Market Share by Applications in 2018

Figure Adult Picture

Figure Children Picture

Figure United States Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure France Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure UK Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure China Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure India Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Mesalamine Revenue (Value) and Growth Rate (2014-2024)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Mesalamine Type and Applications

Table Allergan Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Mesalamine Type and Applications

Table Pfizer Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Mesalamine Type and Applications

Table AstraZeneca Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Salix Pharmaceuticals Mesalamine Type and Applications

Table Salix Pharmaceuticals Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Janssen (Johnson & Johnson) Basic Information, Manufacturing Base and Competitors

Table Janssen (Johnson & Johnson) Mesalamine Type and Applications

Table Janssen (Johnson & Johnson) Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Nogra Pharma Basic Information, Manufacturing Base and Competitors

Table Nogra Pharma Mesalamine Type and Applications

Table Nogra Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors

Table Boehringer Ingelheim Mesalamine Type and Applications

Table Boehringer Ingelheim Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Takeda Basic Information, Manufacturing Base and Competitors

Table Takeda Mesalamine Type and Applications

Table Takeda Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Abbvie Basic Information, Manufacturing Base and Competitors

Table Abbvie Mesalamine Type and Applications

Table Abbvie Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Ferring Basic Information, Manufacturing Base and Competitors

Table Ferring Mesalamine Type and Applications

Table Ferring Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Tillotts Pharma Basic Information, Manufacturing Base and Competitors

Table Tillotts Pharma Mesalamine Type and Applications

Table Tillotts Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Mesalamine Type and Applications

Table Cipla Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Cosmo Pharmaceuticals Mesalamine Type and Applications

Table Cosmo Pharmaceuticals Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Lunan Better Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Lunan Better Pharmaceutical Mesalamine Type and Applications

Table Lunan Better Pharmaceutical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors

Table Chiesi Farmaceutici Mesalamine Type and Applications

Table Chiesi Farmaceutici Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Sandoz Mesalamine Basic Information, Manufacturing Base and Competitors

Table Sandoz Mesalamine Mesalamine Type and Applications

Table Sandoz Mesalamine Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Teva Basic Information, Manufacturing Base and Competitors

Table Teva Mesalamine Type and Applications

Table Teva Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Synmosa Biopharma Corporation Basic Information, Manufacturing Base and Competitors

Table Synmosa Biopharma Corporation Mesalamine Type and Applications

Table Synmosa Biopharma Corporation Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Dr Falk Pharma Basic Information, Manufacturing Base and Competitors

Table Dr Falk Pharma Mesalamine Type and Applications

Table Dr Falk Pharma Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Mesalamine Type and Applications

Table Mylan Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Shanghai Sine Promod Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Shanghai Sine Promod Pharmaceutical Mesalamine Type and Applications

Table Shanghai Sine Promod Pharmaceutical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Mesalamine Sales by Manufacturer (2017-2018)

Figure Global Mesalamine Sales Market Share by Manufacturer in 2017

Figure Global Mesalamine Sales Market Share by Manufacturer in 2018

Table Global Mesalamine Revenue by Manufacturer (2017-2018)

Figure Global Mesalamine Revenue Market Share by Manufacturer in 2017

Figure Global Mesalamine Revenue Market Share by Manufacturer in 2018

Figure Top 3 Mesalamine Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Mesalamine Manufacturer (Revenue) Market Share in 2018

Figure Global Mesalamine Sales and Growth Rate (2014-2019)

Figure Global Mesalamine Revenue and Growth Rate (2014-2019)

Table Global Mesalamine Sales by Regions (2014-2019)

Table Global Mesalamine Sales Market Share by Regions (2014-2019)

Table Global Mesalamine Revenue by Regions (2014-2019)

Figure Global Mesalamine Revenue Market Share by Regions (2014-2019)

Figure Global Mesalamine Revenue Market Share by Regions in 2018

Figure North America Mesalamine Sales and Growth Rate (2014-2019)

Figure Europe Mesalamine Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Mesalamine Sales and Growth Rate (2014-2019)

Figure South America Mesalamine Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Mesalamine Sales and Growth Rate (2014-2019)

Figure North America Mesalamine Revenue and Growth Rate (2014-2019)

Table North America Mesalamine Sales by Countries (2014-2019)

Table North America Mesalamine Sales Market Share by Countries (2014-2019)

Figure North America Mesalamine Sales Market Share by Countries (2014-2019)

Figure North America Mesalamine Sales Market Share by Countries in 2018

Table North America Mesalamine Revenue by Countries (2014-2019)

Table North America Mesalamine Revenue Market Share by Countries (2014-2019)

Figure North America Mesalamine Revenue Market Share by Countries (2014-2019)

Figure North America Mesalamine Revenue Market Share by Countries in 2018

Figure United States Mesalamine Sales and Growth Rate (2014-2019)

Figure Canada Mesalamine Sales and Growth Rate (2014-2019)

Figure Mexico Mesalamine Sales and Growth Rate (2014-2019)

Figure Europe Mesalamine Revenue and Growth Rate (2014-2019)

Table Europe Mesalamine Sales by Countries (2014-2019)

Table Europe Mesalamine Sales Market Share by Countries (2014-2019)

Table Europe Mesalamine Revenue by Countries (2014-2019)

Figure Europe Mesalamine Revenue Market Share by Countries (2014-2019)

Figure Europe Mesalamine Revenue Market Share by Countries in 2018

Figure Germany Mesalamine Sales and Growth Rate (2014-2019)

Figure UK Mesalamine Sales and Growth Rate (2014-2019)

Figure France Mesalamine Sales and Growth Rate (2014-2019)

Figure Russia Mesalamine Sales and Growth Rate (2014-2019)

Figure Italy Mesalamine Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Mesalamine Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Mesalamine Sales by Countries (2014-2019)

Table Asia-Pacific Mesalamine Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Mesalamine Sales Market Share by Countries 2018

Table Asia-Pacific Mesalamine Revenue by Countries (2014-2019)

Figure Asia-Pacific Mesalamine Revenue Market Share by Countries 2018

Figure China Mesalamine Sales and Growth Rate (2014-2019)

Figure Japan Mesalamine Sales and Growth Rate (2014-2019)

Figure Korea Mesalamine Sales and Growth Rate (2014-2019)

Figure India Mesalamine Sales and Growth Rate (2014-2019)

Figure Southeast Asia Mesalamine Sales and Growth Rate (2014-2019)

Figure South America Mesalamine Revenue and Growth Rate (2014-2019)

Table South America Mesalamine Sales by Countries (2014-2019)

Table South America Mesalamine Sales Market Share by Countries (2014-2019)

Figure South America Mesalamine Sales Market Share by Countries in 2018

Table South America Mesalamine Revenue by Countries (2014-2019)

Table South America Mesalamine Revenue Market Share by Countries (2014-2019)

Figure South America Mesalamine Revenue Market Share by Countries in 2018

Figure Brazil Mesalamine Sales and Growth Rate (2014-2019)

Figure Argentina Mesalamine Sales and Growth Rate (2014-2019)

Figure Colombia Mesalamine Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Mesalamine Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Mesalamine Sales by Countries (2014-2019)

Table Middle East and Africa Mesalamine Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Mesalamine Sales Market Share by Countries in 2018

Table Middle East and Africa Mesalamine Revenue by Countries (2014-2019)

Table Middle East and Africa Mesalamine Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Mesalamine Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Mesalamine Revenue Market Share by Countries in 2018

Figure Saudi Arabia Mesalamine Sales and Growth Rate (2014-2019)

Figure UAE Mesalamine Sales and Growth Rate (2014-2019)

Figure Egypt Mesalamine Sales and Growth Rate (2014-2019)

Figure Nigeria Mesalamine Sales and Growth Rate (2014-2019)

Figure South Africa Mesalamine Sales and Growth Rate (2014-2019)

Table Global Mesalamine Sales by Type (2014-2019)

Table Global Mesalamine Sales Share by Type (2014-2019)

Table Global Mesalamine Revenue by Type (2014-2019)

Table Global Mesalamine Revenue Share by Type (2014-2019)

Figure Global Capsule Sales Growth (2014-2019)

Figure Global Capsule Price (2014-2019)

Figure Global Tablets Sales Growth (2014-2019)

Figure Global Tablets Price (2014-2019)

Table Global Mesalamine Sales by Application (2014-2019)

Table Global Mesalamine Sales Share by Application (2014-2019)

Figure Global Adult Sales Growth (2014-2019)

Figure Global Children Sales Growth (2014-2019)

Figure Global Mesalamine Sales, Revenue and Growth Rate (2019-2024)

Table Global Mesalamine Sales Forecast by Regions (2019-2024)

Table Global Mesalamine Market Share Forecast by Regions (2019-2024)

Figure North America Sales Mesalamine Market Forecast (2019-2024)

Figure Europe Sales Mesalamine Market Forecast (2019-2024)

Figure Asia-Pacific Sales Mesalamine Market Forecast (2019-2024)

Figure South America Sales Mesalamine Market Forecast (2019-2024)

Figure Middle East and Africa Sales Mesalamine Market Forecast (2019-2024)

Table Global Mesalamine Sales Forecast by Type (2019-2024)

Table Global Mesalamine Market Share Forecast by Type (2019-2024)

Table Global Mesalamine Sales Forecast by Application (2019-2024)

Table Global Mesalamine Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Allergan

Pfizer

AstraZeneca

Salix Pharmaceuticals

Janssen (Johnson & Johnson)

Nogra Pharma

Boehringer Ingelheim

Takeda

Abbvie

Ferring

Tillotts Pharma

Cipla

Cosmo Pharmaceuticals

Lunan Better Pharmaceutical

Chiesi Farmaceutici

Sandoz Mesalamine

Teva

Synmosa Biopharma Corporation

Dr Falk Pharma

Mylan

Shanghai Sine Promod Pharmaceutical